271 From Clinical to Genotypic Modeling: Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.347
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Recessive Dystrophic Epidermolysis Bullosa Inversa

2020English

390 miR-29 Regulates Type VII Collagen in Individuals With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis Bullosa

New England Journal of Medicine
Medicine
2010English

Induced Pluripotent Stem Cells From Individuals With Recessive Dystrophic Epidermolysis Bullosa

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2011English

Image Gallery: Multiple Localized Lipoatrophy in Recessive Dystrophic Epidermolysis Bullosa

British Journal of Dermatology
DermatologyMedicine
2019English

Mesenchymal Stem Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa: Prospects and Clinical Progress

Expert Opinion on Orphan Drugs
ToxicologyPharmaceuticsPharmacologyHealth Policy
2016English

935 Clinical Manifestations and Quality of Life in Patients With Recessive Dystrophic Epidermolysis Bullosa

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Generation of Keratinocytes From Normal and Recessive Dystrophic Epidermolysis Bullosa-Induced Pluripotent Stem Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Gentamicin Induces Functional Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa Patients

Journal of Clinical Investigation
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy